Pfizer PBC 125 (Ibrance 125 mg)
Generic Name: palbociclib
Pill with imprint Pfizer PBC 125 is Tan, Capsule-shape and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc..
Ibrance is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for Pfizer PBC 125
More about Ibrance (palbociclib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 30 Reviews – Add your own review/rating
- Drug class: CDK 4/6 inhibitors
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.